Every claim, every source.

This NEJM review summarizes evidence that intermittent fasting regimens — alternate-day fasting, time-restricted eating, and periodic multi-day fasts — engage a "metabolic switch" from glucose-derived energy to fat- and ketone-derived energy after hepatic glycogen is depleted, typically within 12–36 hours of fasting depending on the individual and the protocol. The authors argue that repeated exposure to this switch produces adaptive responses across organ systems, including improved insulin sensitivity, reduced inflammation, increased mitochondrial biogenesis, enhanced autophagy, and improved stress resistance in cells. The review compiles findings from animal models alongside the available human trials at the time of publication. The review notes that, despite preclinical signals being strong and consistent, the human evidence base is more heterogeneous: the largest gains in metabolic markers (fasting insulin, HOMA-IR, lipid profile, inflammatory markers) appear in adults with obesity or metabolic syndrome, while effects in lean, metabolically healthy individuals are smaller. The authors flag practical issues — adherence over months, the early-fast hunger and irritability phase, and the lack of long-term outcome data — as the main barriers to clinical adoption rather than safety in healthy adults.

This Nature Reviews Neuroscience paper from Mark Mattson — the most cited researcher on fasting and brain health — synthesizes the case that periodic shifts between fed and fasted metabolic states are essential for optimal brain function. Mattson coined the term "intermittent metabolic switching" (IMS) for the pattern: eating depletes liver glycogen, fasting forces ketone production, and the cycle repeats. The review argues this oscillation is what humans evolved with, and that modern continuous-feeding patterns disrupt it with cognitive and neurological consequences. The mechanistic story focuses on β-hydroxybutyrate (BHB), which is transported into neuronal mitochondria as fuel but also acts as a signaling molecule. BHB induces brain-derived neurotrophic factor (BDNF), which promotes synaptic plasticity, neurogenesis in the hippocampus, and resistance to neuronal injury. Mattson reviews evidence connecting IMS to improved cognition, mood regulation, motor performance, autonomic-nervous-system function, and resistance to neurodegenerative disease. The framework has shaped subsequent fasting-and-brain-health research and is heavily cited in popular literature on fasting's cognitive benefits.

The FASTER (Fat-Adapted Substrate utilization in Trained Elite Runners) study compared 20 elite ultra-endurance athletes — 10 habitually consuming a high-carbohydrate diet (59 percent carbs) and 10 long-term keto-adapted (10 percent carbs, 70 percent fat, average 20 months on the diet) — across maximal and submaximal exercise testing. The headline finding was record-setting: peak fat oxidation in the keto-adapted athletes was 2.3-fold higher than in the carb-adapted group (1.54 vs 0.67 grams per minute), the highest fat-oxidation rates ever recorded in humans during exercise. During submaximal exercise (3-hour run at 64 percent VO2max), fat contributed 88 percent of the energy in keto-adapted athletes versus 56 percent in carb-adapted athletes. Notably, muscle glycogen utilization and post-exercise glycogen repletion were similar between groups despite the dramatic substrate-source shift — meaning keto-adapted athletes used proportionally less carbohydrate from glycogen stores during the run, so their glycogen actually lasted longer. The paper transformed how the field thinks about athletic substrate use: humans can adapt to fat as their dominant fuel without losing the ability to use carbohydrate when it matters.

This Trends in Endocrinology and Metabolism review reframes how the body uses ketone bodies — particularly β-hydroxybutyrate (βOHB) — beyond their traditional role as fuel. Newman and Verdin synthesize evidence that βOHB acts as a signaling molecule through at least two mechanisms. First, βOHB binds at least two cell-surface G-protein-coupled receptors (HCAR2/GPR109A and FFAR3/GPR41), modulating lipolysis, sympathetic tone, and metabolic rate. Second, βOHB directly inhibits class I histone deacetylases (HDACs), which means circulating ketones during fasting or ketogenic diets alter gene expression by changing how DNA is packaged. The review traces implications for caloric restriction, longevity, and aging-related diseases. The paper is a key citation for any claim that ketogenic diets and fasting do work beyond "running on fat instead of carbs" — they trigger gene-expression changes via epigenetic mechanisms with downstream effects on stress resistance, inflammation, and metabolic flexibility. The review is highly cited and has shaped how mechanistic ketosis research is framed.

This is the cleanest human RCT demonstrating that caloric restriction stimulates measurable mitochondrial biogenesis in skeletal muscle. Civitarese and colleagues at Pennington Biomedical Research Center randomized 36 overweight non-obese adults to one of three 6-month interventions: 25 percent calorie restriction (CR), 12.5 percent caloric restriction plus 12.5 percent increase in energy expenditure through exercise (CREX), or weight-maintenance control. Skeletal muscle biopsies were taken at baseline and after 6 months. Both intervention arms showed substantial increases in mitochondrial DNA content — 35 percent in the CR group and 21 percent in the CREX group — with no change in controls. Gene expression of mitochondrial biogenesis regulators rose in both intervention arms: PPARGC1A (PGC-1α), TFAM (mitochondrial transcription factor A), eNOS, SIRT1, and PARL all increased. Notably, the activity of TCA-cycle and beta-oxidation enzymes did not change despite the rise in mitochondrial DNA — suggesting CR produces more mitochondria with similar individual functional capacity, increasing total cellular mitochondrial capacity. DNA damage was reduced in both intervention arms. The paper is the foundational human evidence that caloric restriction does engage the mitochondrial-biogenesis pathway downstream of PGC-1α.

This 2006 PNAS paper from Rafael de Cabo's group at the National Institute on Aging is the foundational rodent mechanistic study for the calorie-restriction → mitochondrial-biogenesis pathway. The researchers fed mice a 40 percent calorie-restricted diet for 6 months and analyzed mitochondrial dynamics in liver and muscle. Three findings are central. First, CR mitochondria consume less oxygen, maintain lower membrane potential, and generate fewer reactive oxygen species than ad-libitum controls — yet they preserve ATP output. The interpretation: CR produces "more efficient" mitochondria that get the same energetic work done with less oxidative collateral damage. Second, the underlying transcriptional driver is PGC-1α (PPARGC1A), which acts via downstream nuclear respiratory factors NRF1 and NRF2 to coordinate mitochondrial biogenesis. Third, eNOS-driven nitric oxide signaling appears to be required: CR-conditioned serum induces mitochondrial biogenesis in cultured myotubes, and the effect is blocked by NO synthesis inhibitors. The paper articulated the molecular framework — PGC-1α, NRFs, eNOS-NO, SIRT1 — that subsequent human studies (Civitarese 2007) confirmed and refined.

Richard Veech's 2004 review is the most-cited mechanistic argument that ketone bodies — specifically D-β-hydroxybutyrate — are not just an alternative fuel but a more efficient one in metabolic terms. Veech's central claim is that the enthalpy of D-β-hydroxybutyrate combustion is higher per unit oxygen consumed than glucose, meaning more ATP per oxygen molecule. He uses this thermodynamic observation to argue that mild ketosis may be therapeutically useful in conditions where mitochondrial efficiency is compromised: insulin resistance, neurodegeneration, ischemia, and certain rare metabolic disorders. The review covers redox state changes during ketosis (favorable shifts in NAD+/NADH), the role of free fatty acid elevation alongside ketones in ketogenic-diet states, and the activation of PPAR signaling. Veech's framing seeded the modern field of "exogenous ketones as therapy" and is widely cited in research on ketogenic diets for epilepsy, Alzheimer's disease, and traumatic brain injury. The therapeutic claims are speculative for many of the listed conditions; the underlying biochemistry is rigorous.

This small but mechanistically important crossover trial asked a focused question: does substituting fish oil for visible dietary fat — without changing total calories or other diet composition — actually shift body fat mass and substrate oxidation? Six healthy young volunteers (five men, mean age 23, normal BMI) ate a controlled diet for three weeks, then 10–12 weeks later ate the same diet with 6 grams per day of visible fat replaced by 6 grams of fish oil for another three weeks. The fish-oil arm produced a small but statistically significant body-fat-mass reduction relative to control (-0.88 vs -0.3 kg). Basal respiratory quotient dropped (0.815 to 0.834), indicating a shift toward fat as the primary fuel at rest. Basal lipid oxidation rose roughly 22 percent (1.06 vs 0.87 mg/kg/min). Resting metabolic rate adjusted for lean body mass was unchanged — meaning the body wasn't burning more calories overall, just shifting the substrate mix toward fat oxidation. The paper is one of the cleanest demonstrations that fish-oil intake can shift substrate metabolism in healthy adults independent of overall calorie change.

Five well-trained cyclists ate their usual mixed diet for one week, then switched to a ketogenic diet — under 20 grams of carbohydrate per day — for four weeks. Calories and protein were matched between both diets; only the fuel source changed. After four weeks of ketosis, the cyclists could ride to exhaustion just as long as before (about 150 minutes), and their peak aerobic capacity (VO2max) was unchanged. What did change was where the energy came from. At the same exercise intensity, the body burned roughly three times less glucose and four times less muscle glycogen. The respiratory quotient — the ratio that tells you whether you're burning carbs or fat — dropped from 0.83 (mostly carbs) to 0.72 (almost entirely fat). The study was an early demonstration that humans can stay in ketosis for weeks and still perform endurance work, drawing energy almost entirely from fat and ketones.

George Cahill's 1970 NEJM review remains the single most important paper ever written on human starvation metabolism. Drawing on his lab's careful in-patient studies of obese volunteers undergoing therapeutic fasts (then a common obesity treatment), Cahill mapped the day-by-day fuel transitions that allow humans to survive weeks-to-months of food deprivation: the shift from glucose to fatty acid oxidation in muscle within hours of the last meal, the rise of hepatic ketogenesis over the first few days, and — most consequentially — the progressive switch by the brain from preferring glucose to preferring β-hydroxybutyrate and acetoacetate as primary fuels. This brain-ketone adaptation is what protects body protein. Without it, prolonged fasting would deplete muscle within days through gluconeogenesis demand; with it, daily protein loss falls to a trickle, fat becomes the dominant fuel, and survival extends to the limits of fat reserves. The paper identifies insulin as the principal regulatory hormone of the transitions and remains the foundational citation for almost every modern paper on fasting physiology.